| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/30/2005 | US20050142120 Cells expressing anti-Fc receptor binding components |
| 06/30/2005 | US20050142119 Pluri-differentiated mesenchymal progenitor cell for use as tissue propagation tool in regenerative medicine; tissue engineering and repair |
| 06/30/2005 | US20050142118 Human cord blood derived unrestricted somatic stem cells (USSC) |
| 06/30/2005 | US20050142115 Papilloma pseudovirus and preparation |
| 06/30/2005 | US20050142103 Mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood by administration of an inhibitor of GTPases such as Rac1 and Rac2 alone or in combination; specifically, methods are disclosed for mobilizing hematopoietic stem cells into subject's peripheral blood; treating cancer, anemia |
| 06/30/2005 | US20050139556 Conveying blood through a line connected between blood donor and storage container without flow interruption whereby blood is centrifuged in-line and pumped through in-line finishing device to remove leukocytes prior to filling container |
| 06/30/2005 | CA2550581A1 Antimicrobial composition comprising a peptide derived from k-casein and a divalent cation |
| 06/30/2005 | CA2550106A1 Lactic acid producing bacteria and lung function |
| 06/30/2005 | CA2550060A1 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
| 06/30/2005 | CA2549930A1 Cd34+ stem cells |
| 06/30/2005 | CA2549000A1 Method for treating neurological disorders |
| 06/30/2005 | CA2546979A1 A biological active blood serum, methods of producing it and uses thereof |
| 06/29/2005 | EP1548118A2 Complementary adenoviral vector systems and cell lines |
| 06/29/2005 | EP1548100A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by Wnt factors |
| 06/29/2005 | EP1547626A2 Carrier with solid fibrinogen and solid thrombin |
| 06/29/2005 | EP1547607A1 Bacterial cell wall skeleton component preparation |
| 06/29/2005 | EP1547606A1 Method of preparing platelet rich plasma |
| 06/29/2005 | EP1546719A2 Isolation and identification of t cells |
| 06/29/2005 | EP1546451A1 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546361A1 Auto-stimulating cells and method for making and using the same |
| 06/29/2005 | EP1546360A2 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 06/29/2005 | EP1546317A1 Methods of quantifying methotrexate metabolites |
| 06/29/2005 | EP1546310A2 Immunomodulating compositions, processes for their production and uses therefor |
| 06/29/2005 | EP1546308A1 A method of treating an autoimmune disease |
| 06/29/2005 | EP1546307A2 Cells on a support matrix for tissue repair |
| 06/29/2005 | EP1546173A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 06/29/2005 | EP1546172A2 Control sequences of the human corin gene |
| 06/29/2005 | EP1545708A2 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 06/29/2005 | EP1545610A2 Epitope sequences |
| 06/29/2005 | EP1545567A1 Pharmaceutical kits comprising mesenchymal stem cells |
| 06/29/2005 | EP1545565A1 Methods and compositions for tissue regeneration |
| 06/29/2005 | EP1545219A2 Cell therapy for regeneration |
| 06/29/2005 | EP1545216A2 Compositions and methods for inhibiting pathogenic growth |
| 06/29/2005 | EP1545204A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 06/29/2005 | EP1401271A4 Method and apparatus for reducing pathogens in a biological sample |
| 06/29/2005 | EP1309672B1 Method of producing infectious reovirus |
| 06/29/2005 | EP1224462B1 Isoagglutinin-depleted blood compositions and methods of making same |
| 06/29/2005 | EP0954326B1 A process for viral inactivation of lyophilized blood proteins |
| 06/29/2005 | CN1633448A Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 06/29/2005 | CN1633259A Integrated herd management system utilizing isolated populations of X-chromosome bearing and Y-chromosome bearing spermatozoa |
| 06/29/2005 | CN1633243A Pet food composition for skin photoprotection |
| 06/29/2005 | CN1632116A Enhancement of virus-mediated DNA transfer |
| 06/29/2005 | CN1631378A Chicken gallbladder extractum dripping pills and its preparation method |
| 06/29/2005 | CN1631374A Safety compound biologic calcium formulation |
| 06/29/2005 | CN1208463C Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 06/29/2005 | CN1208450C Method for the purification, recovery, and sporulation of cysts and oocysts |
| 06/29/2005 | CN1208086C Reptile phrynosoma tablet for treating pulmonary disease |
| 06/29/2005 | CN1208079C Medicine for treating burn scald and frostbite |
| 06/29/2005 | CN1208075C Preparation method of healthy fermentative wine |
| 06/29/2005 | CN1208073C Ointment for treating various skin diseases and preparation method thereof |
| 06/29/2005 | CN1208072C Capsule for treating rheumatism, osteoporosis and hyperosteogeny disease and preparation method thereof |
| 06/29/2005 | CN1208069C Process for preparing liquid medicine to treat dermatopathy |
| 06/29/2005 | CN1208067C Powder medicine for treating otitis media and preparation method thereof |
| 06/29/2005 | CN1208062C Sea urchin containing preparation and its preparing method |
| 06/28/2005 | US6911427 No-modified hemoglobins and uses therefore |
| 06/28/2005 | US6911324 Induction of beta cell differentiation in human cells |
| 06/28/2005 | US6911227 Gels for encapsulation of biological materials |
| 06/28/2005 | US6911220 Inactivating mature recipient t cells and introducing into a primate recipient fetal or neonatal thymic tissue from a donor of a different species; restoring thymus dependent ability for progenitors to develop into mature t cells |
| 06/28/2005 | US6911212 New bone growth inducing compound of partially demineralized lyophilized allograft bone material having a residual calcium content of 4 to 8% dry weight. |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | US6911207 Cytotoxic T-cell epitopes of the papillomavirus L1-protein and use thereof in diagnostics and therapy |
| 06/28/2005 | US6911202 Introducing cartilage producing cells into the skin contour irregularity thereby effecting cosmetic repair thereof |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | US6911196 Boric Acid, Zinc oxide, Calamine, Cetrimide, Olive Oil, Castor Oil, Cod liver Oil, White Petroleum base, Salicylic Acid, and Tannic Acid |
| 06/28/2005 | US6911178 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex |
| 06/28/2005 | US6911127 Contact assemblies, methods for making contact assemblies, and plating machines with contact assemblies for plating microelectronic workpieces |
| 06/28/2005 | CA2232604C Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 06/28/2005 | CA2133831C Low toxicity interleukin-2 analogues for use in immunotherapy |
| 06/23/2005 | WO2005056780A2 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23. |
| 06/23/2005 | WO2005056054A2 METHODS OF INHIBITING APOPTOSIS USING INDUCERS OF NF-κB |
| 06/23/2005 | WO2005056040A2 Systems and methods related to degradation of uremic toxins |
| 06/23/2005 | WO2005056030A1 Penetration enhancing agent and method of its production from the hemp seeds |
| 06/23/2005 | WO2005056029A1 The traditional chinese medicine preparation for treatment of tumour and method of making and using same |
| 06/23/2005 | WO2005056028A1 A synbiotic product and its application as a carrier of natural bioactive substances in functional food additives |
| 06/23/2005 | WO2005056027A2 Solvent for biogenic active pharmaceutical ingredients |
| 06/23/2005 | WO2005056026A1 Compositions and methods for the treatment of lysosomal storage disorders |
| 06/23/2005 | WO2005056025A1 Methods and composition for transplantation of dopaminergic neurons for parkinson's disease |
| 06/23/2005 | WO2005056024A1 Methods of enhancing stem cell engraftment |
| 06/23/2005 | WO2005055934A2 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 06/23/2005 | WO2005055930A2 Recombinant factor viii having increased specific activity |
| 06/23/2005 | WO2005055737A1 Anti-diarrhea composition containing glutamine |
| 06/23/2005 | WO2005047494A3 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 06/23/2005 | WO2005041860A3 Stem cells for use in locating and targeting tumor cells |
| 06/23/2005 | WO2005007861A3 Method for the production and use of antimicrobial protein-inducing factors obtained from gram-negative bacteria |
| 06/23/2005 | WO2004078928A3 T cell regulation |
| 06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
| 06/23/2005 | US20050137152 Reovirus for the prevention of neoplasia |
| 06/23/2005 | US20050137119 animal extracts derived from poultry comprising insect repellents and attractants, used for controlling insects such as acarina |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136124 Mixing demineralized bone matrix (DBM)with an aqueous solution of a neutral salt and a solubilizer for bone morphogenic proteins (BMP) to liquefy; assaying BMP by enzyme-linked immunosorbent assay to determine osteoinductivity without dialysis |
| 06/23/2005 | US20050136091 Crosslinkable macromers |
| 06/23/2005 | US20050136074 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 06/23/2005 | US20050136066 Providing autologous target diseased cell, treating to increase the levels of one or more primary and costimulatory T cell activation molecules in target diseased cell, attaching bridge molecule to diseased cell, collecting bridged cells |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | US20050136037 Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
| 06/23/2005 | US20050136035 Targeted adenovirus vectors include co-transcribed genes under transcriptional control of the same heterologous transcriptional regulatory element (TRE), wherein a second gene is under translational control of a self processing cleavage sequence or 2A sequence; cell or tissue-targeted therapy; e.g. tumor |
| 06/23/2005 | DE20023640U1 Detecting an embryonic cell surface marker e.g. cartilage-derived morphogenic protein CDMP-1 so as to positively identify viable precursor cells that have entered a post-natal differentiation pathway |
| 06/23/2005 | DE10352822A1 Verwendung einer zusätzlich fermentierten Getreideschlempe zur Vorbeugung und/oder Behandlung erhöhter Blutzucker-Werte Using a fermented grain mash in addition to prevent and / or treat elevated blood glucose levels |
| 06/23/2005 | CA2563543A1 Fat collection and preparation system and method |